After stroke, tPA therapy greatly enhanced the expression of cGAS and the activation of STING in the microglia; it also increased the production of the downstream signals of pTBK1, pIRF3, and IFN-β within the ischemic cortex. This evidence concerns the gene STING1 and stroke disorder.